# 📊 PROJECT STATUS - PIPELINE_2

**Last Updated:** 2025-01-16  
**Version:** 0.1.4  
**Status:** ✅ Figure 1 Complete → 📋 Ready for Figure 2 (ALS vs Control Comparison)

---

## 🎯 **CURRENT MILESTONE: FIGURE 1 - COMPLETED** ✅

### ✅ **What's Done:**
- Dataset characterization (68,968 raw entries → 110,199 valid SNVs)
- G>T mutation identification (8,033 mutations, 7.3% of total)
- Mutation type distribution (12 types characterized)
- Positional analysis framework established
- Seed region comparison implemented
- Professional HTML viewer created

### 📈 **Scientific Questions Answered:**
- **SQ1.1:** Dataset structure & quality ✅
- **SQ1.2:** G>T positional distribution ✅
- **SQ1.3:** Prevalent mutation types ✅

---

## 🚀 **NEXT MILESTONE: FIGURE 2 - ALS vs CONTROL COMPARISON**

### 📋 **Priority Questions to Address:**

#### **🔴 CRITICAL (Must Do First):**
1. **SQ2.1:** Is G>T enriched in ALS vs Control?
   - Chi-squared test / Fisher's exact test
   - Odds Ratio calculation
   - Volcano plot visualization
   
2. **SQ4.1:** Age effect analysis
   - Age distribution check
   - Age-adjusted analysis
   - Critical for validity

#### **🟡 HIGH PRIORITY (Immediate Follow-up):**
3. **SQ2.2:** Positional differences ALS vs Control
   - Position-by-position comparison
   - Seed vs non-seed by group
   
4. **SQ2.3:** miRNA-specific G>T enrichment
   - Per-miRNA analysis
   - FDR correction
   - Top candidates identification

5. **SQ4.2:** Sex effect analysis
6. **SQ4.3:** Technical confounders check

---

## 📊 **ANALYSIS PHASES OVERVIEW**

| Phase | Figure | Status | Priority | Scientific Questions |
|-------|--------|--------|----------|---------------------|
| **Phase 1** | Figure 1 | ✅ Complete | ⭐⭐⭐⭐⭐ | SQ1.1, SQ1.2, SQ1.3 |
| **Phase 2** | Figure 2 | 📋 Ready | ⭐⭐⭐⭐⭐ | SQ2.1, SQ2.2, SQ2.3, SQ2.4 |
| **Phase 3** | Figure 3 | ⏳ Planned | ⭐⭐⭐⭐⭐ | SQ4.1, SQ4.2, SQ4.3 |
| **Phase 4** | Figure 4 | ⏳ Planned | ⭐⭐⭐⭐ | SQ3.1, SQ3.2 |
| **Phase 5** | Figure 5 | 💡 Future | ⭐⭐⭐ | SQ5.1, SQ5.2, SQ3.3 |

---

## 📁 **FILES & DOCUMENTATION STATUS**

### ✅ **Complete:**
- `README.md` - Project overview
- `CHANGELOG.md` - Version history (v0.1.4)
- `FIGURE_LAYOUTS.md` - Figure designs
- `DESIGN_DECISIONS.md` - Design rationale
- `MAINTENANCE_GUIDE.md` - Maintenance instructions
- `ACLARACION_DATOS.md` - Data processing explanation
- `SCIENTIFIC_QUESTIONS_ANALYSIS.md` - Comprehensive analysis plan
- `functions/visualization_functions_v4.R` - Working visualization functions
- `test_figure_1_v4.R` - Validated test script
- `create_html_viewer_v4.R` - HTML viewer generator
- `figure_1_viewer_v4.html` - Interactive viewer

### 🔄 **In Progress:**
- Figure 2 design & implementation (pending sample metadata)

### 📋 **Pending:**
- Sample metadata integration
- Group comparison functions
- Statistical testing framework
- Figure 3-5 implementations

---

## ❓ **BLOCKERS & DEPENDENCIES**

### 🔴 **Critical Information Needed:**
1. **Sample Metadata Location:**
   - Where are ALS vs Control labels?
   - Do we have age/sex information?
   - File format and structure?

2. **Data Structure:**
   - How are samples identified in the main dataset?
   - Sample ID format and mapping?

3. **Clinical Data (if available):**
   - ALSFRS-R scores?
   - Disease duration?
   - Survival information?

### 🟢 **Ready to Proceed Once We Have:**
- Sample grouping information (ALS vs Control)
- Basic demographic data (age, sex)
- Clear mapping between dataset and metadata

---

## 🎯 **RECOMMENDED NEXT ACTIONS**

1. **Immediate (Today):**
   - Locate and examine sample metadata
   - Verify data structure and sample IDs
   - Plan Figure 2 data integration

2. **Short-term (This Week):**
   - Implement group comparison functions
   - Develop statistical testing framework
   - Create Figure 2 visualizations
   - Run confounder analysis

3. **Medium-term (Next 2 Weeks):**
   - Complete Figures 2-4
   - Validate all findings
   - Prepare comprehensive results

---

## 📈 **PROGRESS METRICS**

- **Figures Completed:** 1/5 (20%)
- **Scientific Questions Answered:** 3/16 (19%)
- **Critical Questions Answered:** 0/5 (0%) ← Next focus
- **Code Coverage:** Foundation complete, comparisons pending
- **Documentation:** Comprehensive ✅

---

## 🔄 **VERSION HISTORY**

- **v0.1.4** (2025-01-16): Clarified data labels, updated documentation
- **v0.1.3** (2025-01-16): Corrected mutation format, populated visualizations
- **v0.1.2** (2025-01-16): Enhanced visualizations, English text
- **v0.1.1** (2025-01-16): Initial structure and documentation
- **v0.1.0** (2025-01-16): Project initialization

---

## 📝 **NOTES & OBSERVATIONS**

- **Data Quality:** Excellent - 110,199 valid SNVs, 1,462 miRNAs
- **G>T Detection:** Successful - 8,033 mutations identified
- **Visualization:** Professional and publication-ready
- **Documentation:** Comprehensive and well-organized
- **Next Challenge:** Comparative analysis requires metadata integration

---

**🎉 Major Achievement:** Figure 1 complete with real data, correct format, and clear interpretation!

**🚀 Next Goal:** Implement Figure 2 (ALS vs Control) to test core hypothesis